The 25 references in paper N. Mazina K., I. Sheshunov V., P. Мazin V., Yu. Kislitsin V., E. Markova M., Н. Мазина К., И. Шешунов В., П. Мазин В., Ю. Кислицын В., Е. Маркова М. (2017) “ФАРМАКОЭКОНОМИЧЕСКИЙ АНАЛИЗ ЭФФЕКТИВНОСТИ ПЕРАМПАНЕЛА ПРИ ЛЕЧЕНИИ РЕФРАКТЕРНОЙ ПАРЦИАЛЬНОЙ ЭПИЛЕПСИИ СО ВТОРИЧНОЙ ГЕНЕРАЛИЗАЦИЕЙ И БЕЗ НЕЕ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ // PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM” / spz:neicon:pharmacoeconomics:y:2017:i:1:p:29-38

1
Belousov Yu. B., Belousov D. Yu., Chikina e. S., Grigor’ev V. Yu., Mednikov I. I., Beketov A. S. Kachestvennaya meditsinskaya praktika.
(check this in PDF content)
2
04; 4: 3-89. 2. Vlasov P. N. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2016; (special issue 1): 4-10.
(check this in PDF content)
3
The health of Russia in 2015. Statistical book, Federal state statistics service (Rosstat). ed. by M. A. Dianov [Zdravookhranenie Rossii v 2015 godu. Statisticheskii sbornik Federal’noi sluzhby gosudarstvennoi statistiki (Rosstat). Pod red. M. A. Dianova (in Russian)]. Moscow. 2015. www.gks.ru/free_doc/doc_2015/zdrav15. pdf. Data obrashcheniya: 09.01.2017.
(check this in PDF content)
4
Guekht A., hauser W., Milchakova L., Churillin Y. et al. The epidemiology of epilepsy in Russian Federation. Epilepsy research. 2010; 92: 209-218.
(check this in PDF content)
5
Kolyagin V. V. etiologiya, klassifikatsiya i lechenie epilepsii. Irkutsk: RIO IGIU VA: 2010. URL:http://www.docplayer.ru/28601202etiologiya-klassifikacii-i-lechenie-epilepsii.html. Accessed: 09.01.2017.
(check this in PDF content)
6
Belousov D. Yu., Afanas’eva e. V., efremova e. A. Farmakoekonomicheskii analiz primeneniya perampanela pri rezistentnoi partsial’noi epilepsii. Kachestvennaya klinicheskaya praktika. 2014; 1: 24-39.
(check this in PDF content)
7
Mkrtchyan V. R., Sergeev A. M., Pochigaeva K. I., Shpak I. A. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PhARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2016: 9 (2): 28-37.
(check this in PDF content)
8
Pyadushkina e. A., Frolov M. Yu. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PhARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2016; 9 (3): 38-47.
(check this in PDF content)
9
Burd S. G., Rubleva e. V., Serdyuk S. e. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2015: 10 (115): 29-32.
(check this in PDF content)
10
French J., Krauss G., Biton V. et al. Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304. Neurology. 2012; 79: 589-596.
(check this in PDF content)
11
Krauss G., Serratosa J., Villanueva V. et al. Randomized phase III study 306. Adjunctive perampanel for refractory partial-onset seizures. Neurology. 2012; 78: 1408-1415.
(check this in PDF content)
12
Rogawski M., hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand. 2013: 127 (197): 19-24.
(check this in PDF content)
13
French J., Krauss G., Steinhoff B. et al. evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305. Epilepsia. 2013; 54 (1): 117-125.
(check this in PDF content)
14
Lagae L., Villanueva V., Meador K., et al. Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety. Epilepsia. 2016; 57 (7): 1120-1129.
(check this in PDF content)
15
Steinhoff B., hamer h., Trinka e. et al. A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria. Epilepsy Research. 2014; 108: 986-988.
(check this in PDF content)
16
Karlov V. A., Belyaev O. V., Vlasov P. N., Zhidkova I.A i dr. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2016; (special issue 1): 11-17.
(check this in PDF content)
17
The Website «Farmindeks.rf». www.pharmindex.ru. Accessed: 29.12.2016.
(check this in PDF content)
18
The website of the Federal service of state statistics (Rosstat). www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/ population/demography. Accessed: 29.12.2016.
(check this in PDF content)
19
The Website «Agentstvo prognozirovaniya ekonomiki». www. apecon.ru/Prognoz-inflatsii-v-Rossii. Accessed: 29.12.2016.
(check this in PDF content)
20
The Website «Statbyuro». www.statbureau.org/ru/russia/ inflation-calculators. Accessed: 10.01.2017.
(check this in PDF content)
21
French J. A., Krauss G. L., Wechsler R. T., Wang X. F. et al. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy. Neurology. 2015; 85 (11): 950-7.
(check this in PDF content)
22
The course of economic theory. edited by MN Chepurina, eA Kiseleva [Kurs ekonomicheskoi teorii. Pod red. M. N. Chepurinoi, E. A. Kiselevoi (in Russian)]. Kirov. 2004.
(check this in PDF content)
23
Yagudina R. I., Kulikov A. Yu., Serpik V. G. Pharmacoeconomics [Farmakoekonomika (in Russian)]. Rostov n/D. 2017; 237.
(check this in PDF content)
24
Liu J., Yu N., Sun h., Liang Y., Xie Y., Chen K. Intermittent levetiracetam treatment in five patients with catamenial epilepsy. J Pak Med Assoc. 2015 Jul; 65 (7): 793-5.
(check this in PDF content)
25
Matre e. T., Cook A. M. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients. Neurol Res. 2016 Sep; 38 (9): 786-91. DOI: 10.1080/01616412.2016.1206164. epub 2016 Jul 14. Сведения об авторах:
(check this in PDF content)